Nebreda AR - Search Results

1

Igea A, Gupta J, Nebreda AR. Igea A, et al. Among authors: nebreda ar. Aging (Albany NY). 2015 Aug;7(8):525-6. doi: 10.18632/aging.100796. Aging (Albany NY). 2015. PMID: 26298432 Free PMC article. No abstract available.

2

Expression and functional validation of new p38α transcriptional targets in tumorigenesis.

Swat A, Dolado I, Igea A, Gomez-Lopez G, Pisano DG, Cuadrado A, Nebreda AR. Swat A, et al. Among authors: nebreda ar. Biochem J. 2011 Mar 15;434(3):549-58. doi: 10.1042/BJ20101410. Biochem J. 2011. PMID: 21226672

3

The stress-activated protein kinases p38α/β and JNK1/2 cooperate with Chk1 to inhibit mitotic entry upon DNA replication arrest.

Llopis A, Salvador N, Ercilla A, Guaita-Esteruelas S, Barrantes Idel B, Gupta J, Gaestel M, Davis RJ, Nebreda AR, Agell N. Llopis A, et al. Among authors: nebreda ar. Cell Cycle. 2012 Oct 1;11(19):3627-37. doi: 10.4161/cc.21917. Epub 2012 Aug 30. Cell Cycle. 2012. PMID: 22935704 Free PMC article.

4

Lipid binding by the Unique and SH3 domains of c-Src suggests a new regulatory mechanism.

Pérez Y, Maffei M, Igea A, Amata I, Gairí M, Nebreda AR, Bernadó P, Pons M. Pérez Y, et al. Among authors: nebreda ar. Sci Rep. 2013;3:1295. doi: 10.1038/srep01295. Sci Rep. 2013. PMID: 23416516 Free PMC article.

5

Multi-phosphorylation of the intrinsically disordered unique domain of c-Src studied by in-cell and real-time NMR spectroscopy.

Amata I, Maffei M, Igea A, Gay M, Vilaseca M, Nebreda AR, Pons M. Amata I, et al. Among authors: nebreda ar. Chembiochem. 2013 Sep 23;14(14):1820-7. doi: 10.1002/cbic.201300139. Epub 2013 Jun 6. Chembiochem. 2013. PMID: 23744817

6

Inhibition of p38 MAPK sensitizes tumour cells to cisplatin-induced apoptosis mediated by reactive oxygen species and JNK.

Pereira L, Igea A, Canovas B, Dolado I, Nebreda AR. Pereira L, et al. Among authors: nebreda ar. EMBO Mol Med. 2013 Nov;5(11):1759-74. doi: 10.1002/emmm.201302732. Epub 2013 Sep 24. EMBO Mol Med. 2013. PMID: 24115572 Free PMC article.

7

Dual function of p38α MAPK in colon cancer: suppression of colitis-associated tumor initiation but requirement for cancer cell survival.

Gupta J, del Barco Barrantes I, Igea A, Sakellariou S, Pateras IS, Gorgoulis VG, Nebreda AR. Gupta J, et al. Among authors: nebreda ar. Cancer Cell. 2014 Apr 14;25(4):484-500. doi: 10.1016/j.ccr.2014.02.019. Epub 2014 Mar 27. Cancer Cell. 2014. PMID: 24684847 Free article.

8

Roles of p38α mitogen-activated protein kinase in mouse models of inflammatory diseases and cancer.

Gupta J, Nebreda AR. Gupta J, et al. Among authors: nebreda ar. FEBS J. 2015 May;282(10):1841-57. doi: 10.1111/febs.13250. Epub 2015 Mar 16. FEBS J. 2015. PMID: 25728574 Free PMC article. Review.

9

Pharmacological inhibition of p38 MAPK reduces tumor growth in patient-derived xenografts from colon tumors.

Gupta J, Igea A, Papaioannou M, Lopez-Casas PP, Llonch E, Hidalgo M, Gorgoulis VG, Nebreda AR. Gupta J, et al. Among authors: nebreda ar. Oncotarget. 2015 Apr 20;6(11):8539-51. doi: 10.18632/oncotarget.3816. Oncotarget. 2015. PMID: 25890501 Free PMC article.

10

The Stress Kinase p38α as a Target for Cancer Therapy.

Igea A, Nebreda AR. Igea A, et al. Among authors: nebreda ar. Cancer Res. 2015 Oct 1;75(19):3997-4002. doi: 10.1158/0008-5472.CAN-15-0173. Epub 2015 Sep 16. Cancer Res. 2015. PMID: 26377941 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters